Progression model for pancreatic cancer

Clinical Cancer Research

Volumn 6, Issue 8, 2000, Pages 2969-2972

  Hruban, Ralph H ^a,b   Goggins, Michael ^a   Parsons, Jennifer ^a   Kern, Scott E ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA2 PROTEIN; PROTEIN P16; PROTEIN P53;

CANCER GROWTH; CANCER INFILTRATION; CANCER INVASION; GENE LOSS; GENE MUTATION; GENE OVEREXPRESSION; ONCOGENE K RAS; ONCOGENE NEU; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PRIORITY JOURNAL; SHORT SURVEY; TUMOR SUPPRESSOR GENE;

CARCINOMA, PANCREATIC DUCTAL; DISEASE PROGRESSION; HUMANS; PANCREATIC NEOPLASMS;

EID: 0033887693     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (54)

1. Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Nakamura, Y., White, R., Smits, A. M., and Bos, J. L. Genetic alterations during colorectal-tumor development. N. Engl. J. Med., 319: 525-532, 1988.
2. Vogelstein, B., and Kinzler, K. W. The multistep nature of cancer. Trends Genet., 9: 138-141, 1993.
3. Kinzler, K. W., and Vogelstein, B. Gatekeepers and caretakers. Nature (Lond.), 386: 761-763, 1997.
4. Fearon, E. R., Hamilton, S. R., and Vogelstein, B. Clonal analysis of human colorectal tumors. Science (Washington DC), 238: 193-197, 1987.
5. Powell, S. M., ZiIz, N., Beazer-Barclay, Y., Bryan, T. M., Hamilton, S. R., Thibodeau, S. N., Vogelstein, B., and Kinzler, K. W. APC mutations occur early during colorectal tumorigenesis. Nature (Lond.), 359: 235-237, 1992.
6. Shibata, D., Schaeffer, J., Li, Z. H., Capella, G., and Perucho, M. Genetic heterogeneity of the c-K-ras locus in colorectal adenomas but not in adenocarcinomas [see comments]. J. Natl. Cancer Inst., 85: 1058-1063, 1993.
7. Bos, J. L., Fearon, E. R., Hamilton, S. R., Verlaan-de Vries, M., van Boom, J. H., van der Eb, A. J., and Vogelstein, B. Prevalence of ras gene mutations in human colorectal cancers. Nature (Lond.), 327: 293-297, 1987.
8. Kern, S. E., Fearon, E. R., Tersmette, K. W. F., Enterline, J. P., Leppert, M., Nakamura, Y., White, R., Vogelstein, B., and Hamilton, S. R. Clinical and pathological associations with allelic loss in colorectal carcinoma. J. Am. Med. Assoc., 261: 3099-3103, 1989.
9. Sidransky, D., Tokino, T., Hamilton, S. R., Kinzler, K. W., Levin, B., Frost, P., and Vogelstein, B. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science (Washington DC), 250: 102-105, 1992.
10. Giardiello, F. M., Hamilton, S. R., Krush, A. J., Piantadosi, S., Hylind, L. M., Celano, P., Booker, S. V., Robinson, C. R., and Offerhaus, G. J. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N. Engl. J. Med., 328: 1313-1316, 1993.
11. Almoguera, C., Shibata, D., Forrester, K., Martin, J., Arnheim, N., and Perucho, M. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell, 53: 549-554, 1988.
12. Sommers, S. C., Murphy, S. A., and Warren, S. Pancreatic duct hyperplasia and cancer. Arch. Pathol., 27: 629-640, 1954.
13. Cubilla, A. L., and Fitzgerald, P. J. Morphological lesions associated with human primary invasive nonendocrine pancreas cancer. Cancer Res., 36: 2690-2698, 1976.
14. Kozuka, S., Sassa, R., Taki, T., Masamoto, K., Nagasawa, S., Saga, S., Hasegawa, K., and Takeuchi, M. Relation of pancreatic duct hyperplasia to carcinoma. Cancer (Phila.), 43: 1418-1428, 1979.
15. Furukawa, T., Chiba, R., Kobari, M., Matsuno, S., Nagura, H., and Takahashi, T. Varying grades of epithelial atypia in the pancreatic ducts of humans. Classification based on morphometry and multivariate analysis and correlated with positive reactions of carcinoembryonic antigen. Arch. Pathol. Lab. Med., 118: 227-234, 1994.
16. Klöppel, G., Bommer, G., Rückert, K., and Seifert, G. Intraductal proliferation in the pancreas and its relationship to human and experimental carcinogenesis. Virchows Arch. A Pathol. Anat. Hist., 387: 221-233, 1980.
17. Lüttges, J., Schlehe, B., Menke, M. A., Vogel, I., Henne-Bruns, D., and Klöppel, G. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium. Cancer (Phila.), 85: 1703-1710, 1999.
18. Brat, D. J., Lillemoe, K. D., Yeo, C. J., Warfield, P. B., and Hruban, R. H. Progression of pancreatic intraductal neoplasias (high-grade PanIN) to infiltrating adenocarcinoma of the pancreas. Am. J. Surg. Pathol., 22: 163-169, 1998.
19. Brockie, E., Anand, A., and Albores-Saavedra, J. Progression of atypical ductal hyperplasia/carcinoma in situ of the pancreas to invasive adenocarcinoma. Ann. Diagn. Pathol., 2: 286-292, 1998.
20. Hruban, R. H., Wilentz, R. E., Goggins, M., Offerhaus, G. J. A., Yeo, C. J., and Kern, S. E. Pathology of incipient pancreatic cancer. Ann. Oncol., 10: S9-S11, 1999.
21. Day, J. D., DiGiuseppe, J. A., Yeo, C. J., Loi-Goldman, M., Anderson, S., Kern, S. E., and Hruban, R. H. Immunohistochemical evaluation of HER-2/neu oncogene expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasms. Hum. Pathol., 27: 119-124, 1996.
22. Wilentz, R. E., lacobuzio-Donahue, C. A., Argani, P., McCarthy, D. M., Parsons, J. L., Yeo, C. J., Kern, S. E., and Hruban, R. H. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Cancer Res., 60: 2002-2006, 2000.
23. Wilentz, R. E., Geradts, J., Maynard, R., Offerhaus, G. J. A., Kang, M., Goggins, M., Yeo, C. J., Kern, S. E., and Hruban, R. H. Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression. Cancer Res., 58: 4740-4744, 1998.
24. Moskaluk, C. A., Hruban, R. H., and Kern, S. E. p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma. Cancer Res., 57: 2140-2143, 1997.
25. DiGiuseppe, J. A., Hruban, R. H., Offerhaus, G. J. A., Clement, M. J., van den Berg, F. M., Cameron, J. L., and van Mansfeld, A. D. M. Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma. Am. J. Pathol., 144: 889-895, 1994.
26. DiGiuseppe, J. A., Hruban, R. H., Goodman, S. N., Polak, M., van den Berg, F. M., Allison, D. C., Cameron, J. L., and Offerhaus, G. J. A. Overexpression of p53 protein in adenocarcinoma of the pancreas. Am. J. Clin. Pathol., 101: 684-688, 1994.
27. Goggins, M., Hruban, R. H., and Kern, S. E. BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: evidence and implications. Am. J. Pathol., 756: 1767-1771, 2000
28. Caldas, C., Hahn, S. A., Hruban, R. H., Redston, M. S., Yeo, C. J., and Kern, S. E. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Cancer Res., 54: 3568-3573, 1994.
29. Tada, M., Ohashi, M., Shiratori, Y., Okudaira, T., Komatsu, Y., Kawabe, T., Yoshida, H., Machinami, R., Kishi, K., and Omata, M. Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease. Gastroenterology, 110: 227-231, 1996.
30. Yanagisawa, A., Ohtake, K., Ohashi, K., Hori, M., Kitagawa, T., Sugano, H., and Kato, Y. Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation. Cancer Res., 53: 953-956, 1993.
31. Terhune, P. G., Phifer, D. M., Tosteson, T. D., and Longnecker, D. S. K-ras mutation in focal proliferative lesions of human pancreas. Cancer Epidemiol. Biomark. Prev., 7: 515-521, 1998.
32. Yamano, M., Fujii, H., Takagaki, T., Kadowaki, N., Watanabe, H., and Shirai, T. Genetic progression and divergence in pancreatic carcinoma. Am. J. Pathol., 156: 2123-2133, 2000.
33. Harneed, M., Marrero, A. M., Conlon, K. C., Brennan, M. F., and Klimstra, D. S. Expression of p53 nucleophosphoprotein in in situ pancreatic ductal adenocarcinoma: an immunohistochemical analysis of 100 cases. Lab. Investig., 70: 132A, 1994.
34. Hruban, R. H., Wilentz, R. E., and Kern, S. E. Genetic progression in the pancreatic ducts. Am. J. Pathol., 156: 1821-1825, 2000.
35. Su, G. H., Hilgers, W., Shekher, M., Tang, D., Yeo, C. J., Hruban, R. H., and Kern, S. E. Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor-suppressor gene. Cancer Res., 58: 2339-2342, 1998.
36. Ueki, T., Toyota, M., Sohn, T. A., Yeo, C. J., Issa, J-P. J., Hruban, R. H., and Goggins, M. Hypermethylation of multiple genes in pancreatic carcinoma. Cancer Res., 60: 1835-1839, 2000.
37. Su, G. H., Hruban, R. H., Bova, G. S., Goggins, M., Bansal, R. K., Tang, D. T., Shekher, M. C., Westerman, A-M., Entius, M. M., Yeo. C. J., and Kern, S. E. Germline and somatic mutations of the STK11/ LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers. Am. J. Pathol., 154: 1835-1840, 1999.
38. Goggins, M., Shekher, M., Kenan, T., Yeo, C. J., Hruban, R. H., and Kern, S. E. Genetic alterations of the transforming growth factor β receptor genes in pancreatic and biliary adenocarcinomas. Cancer Res., 58: 5329-5332, 1998.
39. Wilentz, R. E., and Hruban, R. H. Pathology of cancer of the pancreas. Surg. Oncol. Clin. N. Am., 7: 43-65, 1998.
40. Wilentz, R. E., Slebos, R. J. C., and Hruban, R. H. Screening for pancreatic cancer using techniques to detect altered gene products. In: H. A. Reber (ed.), Pancreatic Cancer: Pathogenesis, Diagnosis, and Treatment, pp. 113-136. Totowa, NJ: Humana Press, Inc., 1997.
41. Berthélemy, P., Bouisson, M., Escourrou, J., Vaysse, N., Rumeau, J. L., and Pradayrol, L. Identification of K-ras mutations in pancreatic juice in the early diagnosis of pancreatic cancer. Ann. Intern. Med., 123: 188-191, 1995.
42. Tada, M., Omata, M., Kawai, S., Saisho, H., Ohto, M., Saiki, R. K., and Sninsky, J. J. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. Cancer Res., 53: 2472-2474, 1993.
43. Brentnall, T. A., Bronner, M. P., Byrd, D. R., Haggitt, R. C., and Kimmey, M. B. Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Ann. Intern. Med., 131: 247-255, 1999.
44. Wilentz, R. E., Chung, C. H., Sturm, P. D. J., Musler, A., Sohn, T. A., Offerhaus, G. J. A., Yeo, C. J., Hruban, R. H., and Slebos, R. J. C. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma. Cancer (Phila.), 82: 96-103, 1998.
45. Hong, W. K., and Sporn, M. B. Recent advances in chemoprevention of cancer. Science (Washington DC), 278: 1073-1077, 1997.
46. Tucker, O. N., Dannenberg, A. J., Yang, E. K., Zhang, F., Teng, L., Daly, J. M., Soslow, R. A., Masferrer, J. L., Woerner, B. M., Koki, A. T., and Fahey, T. J. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res., 59: 987-990, 1999.
47. Goggins, M., Schutte, M., Lu, J., Moskaluk, C. A., Weinstein, C. L., Petersen, G. M., Yeo, C. J., Jackson, C. E., Lynch, H. T., Hruban, R. H., and Kern, S. E. Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res., 56: 5360-5364, 1996.
48. Goldstein, A. M., Fraser, M. C., Struewing, J. P., Hussussian, C. J., Ranade, K., Zametkin, D. P., Fontaine, L. S., Organic, S. M., Dracopoli, N. C., Clark, W. H., and Tucker, M. A. Increased risk of pancreatic cancer in melanoma-prone kindreds with p16 INK4 mutations. N. Engl. J. Med., 333: 970-974, 1995.
49. INK4 allele (Asp145Cys) in a family with multiple pancreatic carcinomas. Hum. Mutat., 12: 70, 1998.
50. Lowenfels, A. B., Maisonneuve, E. P., Dimagno, Y. E., Gates, L. K., Perrault, J., Whitcomb, D. C., and International Hereditary Pancreatitis Study Group. Hereditary pancreatitis and the risk of pancreatic cancer. J. Natl. Cancer Inst., 89: 442-446, 1997.
51. Hruban, R. H., Petersen, G. M., Goggins, M., Tersmette, A. C., Offerhaus, G. J. A., Falatko, F., and Kern, S. E. Familial pancreatic cancer. Ann. Oncol., 10: S69-S73, 1999.
52. Hruban, R. H., Petersen, G. M., Ha, P. K., and Kern, S. E. Genetics of pancreatic cancer: From genes to families. Surg. Oncol. Clin. N. Am., 7: 1-23, 1998.
53. Nascimbeni, R., Villanacci, V., Mariani, P. P., Di Betta, E., Ghirardi, M., Donato, F., and Salerni, B. Aberrant crypt foci in the human colon: frequency and histologic patterns in patients with colorectal cancer or diverticular disease. Am. J. Surg. Pathol., 23: 1256-1263, 1999.
54. +. Am. J. Pathol., 152: 1501-1507, 1998.